Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

Diabetes Symptoms and Prediabetes Signs Most People Overlook — Early Warnings for Type 2 Diabetes

Discover hidden diabetes symptoms, prediabetes signs, and type 2 diabetes early symptoms that many overlook to catch warning signs and protect your health early.

Medical Daily

This Medical Device Maker Is Seeing High Demand In Cardiovascular, Diabetes Business

Medtronic Plc (NYSE:MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase year-over-year, with organic growth of 5.5%.

Benzinga

With $199 Price, Ozempic Prescriptions Expected to Soar — Experts Warn of Risks

Novo Nordisk's new $199 offer for Ozempic and Wegovy aims to improve access for obesity and diabetes treatments, but experts warn of potential serious side effects.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Medication Interactions Pharmacists Are Told Not To Discuss

Seniors often juggle multiple prescriptions, making drug interactions a serious concern. While pharmacists are trained to catch dangerous combinations, not all interactions are openly discussed....

Saving Advice

New drug could prevent diabetes complications not fixed with blood sugar control, study hints

An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells.

LiveScience

Five-year title sponsor extension solidifies Team Novo Nordisk through 2031

Roster of 20 riders confirmed for 'truly amazing journey' of 15th season for ProTeam comprised of athletes living with diabetes

Cycling News

Diabetes app for young people hailed as ‘go-to resource’ rolled out

The Digibete platform is now being used by more than 3,000 people across Scotland following a ‘highly successful’ scale-up programme.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Scientists have discovered why type 1 diabetes is worse for young children

Type 1 diabetes is more severe and aggressive in young children and scientists have now discovered why

The Independent UK

New Trump directive could deny more visas based on applicants' health and finances

A new directive by President Donald Trump’s administration could make it more difficult for foreigners to visit or live in the United States if they have certain medical conditions such as diabetes or obesity or lack the economic resources and assets to support themselves

The Independent UK

US May Deny Visas to Immigrants with Obesity, Cancer or Diabetes Under New State Department Rules

The US State Department has issued a directive allowing visa denials based on chronic health conditions and obesity, expanding the 'public charge' rule and raising concerns about bias and access.

International Business Times UK

The common foods that increase your risk of pre-diabetes

Young people’s consumption of foods high in sodium, sugar, and unhealthy fats is increasing their risk of diabetes, a study has found

The Independent UK

The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep?

Stocks dropped hard last week, but a late-day rally on Friday staved off the worst. The Dow Jones Industrial Average held up the best, only closing down 1.21%. The SP 500 was down 1.63%, but the Nasdaq suffered the most, as it closed down 3.04%. Tech was routed hard as…

Benzinga

Donald Trump Rule: Age, Obesity, Diabetes Trigger US Visa Ban on Public Charge

The Trump administration issued a new directive allowing US visa officers to reject applicants based on obesity, diabetes, and age. The policy flags immigrants as a potential 'public charge.'

International Business Times UK

On the same day as his ‘fat jab’ launch, Trump issued new reason to deny visas to foreigners: obesity

The guidance describes obese foreigners as a ‘public charge’ and orders visa officers to guess how much they would claim in benefits

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Scientists warn common diabetes drug may be cancelling out benefits of exercise

New study raises urgent questions about how doctors treat diabetes

Benzinga

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.

The Independent UK

This is the exercise you need to combat obesity and diabetes, new study says

It’s estimated that more than 5.8 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK

Benzinga

Novo Nordisk Q3 2025 Earnings Call Transcript

Novo Nordisk A/S (NASDAQ:NVO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below. NVO is having a challenging session. See if it is worth your attention here. This transcript is brought to you by Benzinga APIs. For real-time access to our entire…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

What a prediabetic diagnosis means and the food you should avoid

A prediabetic diagnosis can serve as a health warning and encourage lifestyle changes

Evening Standard

London’s unhealthiest high streets revealed with seven among worst in Britain

Communities named face higher risks of obesity, diabetes and heart disease, experts say

The Independent UK

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a bidding war over the drugmaker Metsera

Benzinga

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

DexCom Inc (NASDAQ:DXCM) is facing renewed scrutiny after three people with diabetes reportedly died following issues with its G7 continuous glucose monitor, according to adverse event filings submitted to the Food and Drug Administration in September.

The Conversation

Why are so many millennials getting cancer?

If you’re reading this there’s a good chance that you, like me, are a millennial. If so, you’ve probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later adulthood – hypertension, type 2 diabetes or perhaps even the one that we’re…

Evening Standard

New drug could help prevent sight loss in people with diabetes, study suggests

The study was led by researchers at Queen’s University Belfast.

The Independent UK

Wood burning fires in homes linked to 2,500 deaths a year in the UK, report says

Wood burners produce a fine particulate matter linked to thousands of asthma and diabetes cases

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

the Food and Drug Administration

200 stories

The US State Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.